Rafarma Pharmaceuticals, Inc.

Equities

RAFA

US75062C1009

Delayed OTC Markets Other stock markets 20:21:57 16/07/2024 BST			5-day change	1st Jan Change
0.06 ^USD	-1.64%		-14.29%	-77.04%

07-03	Rafarma Pharmaceuticals Establishes A Joint Industrial Venture in Busan Technology Park with Woods Medical Care, Inc	CI
2021	RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park	CI

Rafarma Pharmaceuticals, Inc. Enters New Distribution Agreement with Amber Pharma Distribution Group

September 10, 2013 at 02:05 pm

Rafarma Pharmaceuticals, Inc. announced it has entered into a new multi-year distribution contract with Amber Pharma Distribution Group.

Latest news about Rafarma Pharmaceuticals, Inc.

Rafarma Pharmaceuticals Establishes A Joint Industrial Venture in Busan Technology Park with Woods Medical Care, Inc	07-03	CI
RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park	17/12/21	CI
Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers	07/05/21	CI
Rafarma Pharmaceuticals, Inc. Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan	29/01/21	CI
Vaccines Lab Sdn Bhd Enters Master Strategic Joint Venture Agreement with Rafarma Pharmaceuticals Inc	15/12/20	CI
Rafarma Pharmaceuticals, Inc. Signs a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia	01/12/20	CI
R. & D. Biocogency Laboratories Inc. Ltd. completed the acquisition of an unknown majority stake in Rafarma Pharmaceuticals, Inc..	18/10/20	CI
Rafarma Pharmaceuticals, Inc. Appoints Ilia Shpurov as Chairman of the Board	18/09/20	CI
Rafarma Establishes Thailand Corporate Entity for Merger and Expansion Projects	25/08/20	CI
R. & D. Biocogency Laboratories Inc. Ltd. agreed to acquire an unknown majority stake in Rafarma Pharmaceuticals, Inc..	03/08/20	CI
Rafarma Pharmaceuticals, Inc. Announces Finalization of the Agreement with Destination Marketing Group Co. Ltd	22/06/20	CI
Rafarma Pharmaceuticals, Inc. Announces Commencement of Tests for Its New Product Hempysleep	15/06/20	CI
Rafarma Appoints Vladislav N. Laskav as Board Member	06/04/20	CI
Rafarma Pharmaceuticals, Inc. Agrees Terms to Open Its First Specialized Cannabis Spa in Europe	23/03/20	CI
Rafarma Pharmaceuticals Inc. Officially Begun Research Programs with Khon Kaen University in Thailand	24/02/20	CI
Rafarma Announces Cooperative Research Programs with the Faculty of Medicine, Khon Kaen University, Thailand	10/02/20	CI
Rafarma Pharmaceuticals, Inc. Closes Exclusive Joint Venture Agreement with MTP Material Co. Ltd	21/01/20	CI
Rafarma Pharmaceuticals, Inc. Appoints Anucha Phetpheng as New Executive Vice-President for Thai Operations	09/01/20	CI
Rafarma to Commence Production in Thailand	23/08/19	CI
Rafarma Pharmaceuticals, Inc. Appoints Vladimir Dolgolenko as CEO and President	12/07/19	CI
Rafarma’s Blockchain Tech Ready for Thailand’s Approved Uses of Cannabis	08/07/19	CI
Panaxia Pharmaceutical Industries and Rafa Sign A Collaboration Agreement with PlantEXT to Research and Manufacture the First Medical Cannabis Suppositories Intended for Patients Suffering from Inflammatory Bowel Disease	01/05/19	CI
Open Joint Stock Company Protek completed the acquisition of Joint Stock Company Rafarma from Rafarma Pharmaceuticals, Inc..	17/04/17	CI
Rafarma Pharmaceuticals Inc. Appoints Mr. Bruno Horn as New President and Director	30/07/14	CI
Rafarma Pharmaceuticals Announces the Complete Restructuring of Existing EUR 90,000,000 Loan with VNeshconombank	02/04/14	CI

Chart Rafarma Pharmaceuticals, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company